Co-Authors
This is a "connection" page, showing publications co-authored by Ajay Kirtane and Mahesh Madhavan.
Connection Strength
0.447
-
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA. 2021 04 27; 325(16):1620-1630.
Score: 0.059
-
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial. Thromb Haemost. 2022 Jan; 122(1):131-141.
Score: 0.059
-
Pulmonary Embolism Response Team utilization during the COVID-19 pandemic. Vasc Med. 2021 08; 26(4):426-433.
Score: 0.059
-
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19. Nat Commun. 2021 02 26; 12(1):1325.
Score: 0.058
-
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies. Thromb Res. 2020 12; 196:382-394.
Score: 0.057
-
Extrapulmonary manifestations of COVID-19. Nat Med. 2020 07; 26(7):1017-1032.
Score: 0.056
-
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol. 2020 05 12; 75(18):2352-2371.
Score: 0.055
-
Percutaneous coronary intervention of bifurcation lesions and platelet reactivity. Int J Cardiol. 2018 Jan 01; 250:92-97.
Score: 0.046